Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

Download this short slideset of key takeaways from a live CCO Webinar focused on the optimal use of BTK inhibitors in patients with CLL.

Danielle Brander, MD Nicole Lamanna, MD Jeff P. Sharman, MD Released: July 10, 2020

Downloadable slides with expert analysis of the BCR pathway and BTK inhibitors in CLL.

Jeff P. Sharman, MD Released: June 10, 2020

Downloadable slides with expert analysis of potential future applications for BTK inhibitors.

Jeff P. Sharman, MD Released: June 10, 2020

Downloadable slides with expert analysis of the use of BTK inhibitors for patients with treatment-naive CLL.

Danielle Brander, MD Released: June 10, 2020

Downloadable slides with expert analysis of the optimal use of BTK inhibitors in patients with relapsed/refractory CLL.

Nicole Lamanna, MD Released: June 10, 2020